Literature DB >> 18021909

Increasing the demand for and use of effective smoking-cessation treatments reaping the full health benefits of tobacco-control science and policy gains--in our lifetime.

C Tracy Orleans1.   

Abstract

More adults in the United States have quit smoking than remain current smokers. But 45 million adults (20.9%) continue to smoke, with highest rates among low socioeconomic status (SES), blue-collar, and Native American populations. More than two thirds (70%) of adult smokers want to quit, and approximately 40% make a serious quit attempt each year, but only 20%-30% of quitters use an effective behavioral counseling or pharmacologic treatment. The lowest rates of treatment use are seen in the populations with the highest rates of tobacco use. Fully harvesting the last 4 decades of progress in tobacco-control science and policy to increase smokers' demand for and use of cessation treatments represents an extraordinary opportunity to extend lives and reduce healthcare costs and burden in the next 30-40 years. This paper uses the "push-pull capacity" model as a framework for illustrating strategies to achieve this goal. This model recommends: (1) improving and communicating effective treatments for wide population use; (2) building the capacity of healthcare and other systems to deliver effective treatments; and (3) boosting consumer, health plan, and insurer demand for them through policy interventions shown to motivate and support quitting (e.g., clean indoor-air laws, tobacco tax increases, expanded insurance coverage/reimbursement) and efforts to improve treatment access and appeal, especially for smokers who use them least. Innovations recommended by the National Consumer Demand Roundtable for achieving "breakthrough" improvements in cessation treatment demand and use are described.

Entities:  

Mesh:

Year:  2007        PMID: 18021909     DOI: 10.1016/j.amepre.2007.09.003

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  44 in total

1.  Smoking cessation quitlines: an underrecognized intervention success story.

Authors:  Edward Lichtenstein; Shu-Hong Zhu; Gary J Tedeschi
Journal:  Am Psychol       Date:  2010 May-Jun

2.  Perceptions of evidence-based programs among community-based organizations tackling health disparities: a qualitative study.

Authors:  Shoba Ramanadhan; Josephine Crisostomo; Jaclyn Alexander-Molloy; Ediss Gandelman; Milagro Grullon; Vilma Lora; Chrasandra Reeves; Clara Savage; Kasisomayajula Viswanath
Journal:  Health Educ Res       Date:  2011-10-19

3.  Exploring scenarios to dramatically reduce smoking prevalence: a simulation model of the three-part cessation process.

Authors:  David T Levy; Patricia L Mabry; Amanda L Graham; C Tracy Orleans; David B Abrams
Journal:  Am J Public Health       Date:  2010-05-13       Impact factor: 9.308

4.  Boosting population quits through evidence-based cessation treatment and policy.

Authors:  David B Abrams; Amanda L Graham; David T Levy; Patricia L Mabry; C Tracy Orleans
Journal:  Am J Prev Med       Date:  2010-03       Impact factor: 5.043

5.  Reaching Healthy People 2010 by 2013: A SimSmoke simulation.

Authors:  David T Levy; Patricia L Mabry; Amanda L Graham; C Tracy Orleans; David B Abrams
Journal:  Am J Prev Med       Date:  2010-03       Impact factor: 5.043

6.  Modeling the impact of smoking-cessation treatment policies on quit rates.

Authors:  David T Levy; Amanda L Graham; Patricia L Mabry; David B Abrams; C Tracy Orleans
Journal:  Am J Prev Med       Date:  2010-03       Impact factor: 5.043

7.  Helping smokers quit: understanding the barriers to utilization of smoking cessation services.

Authors:  Sarah E Gollust; Steven A Schroeder; Kenneth E Warner
Journal:  Milbank Q       Date:  2008-12       Impact factor: 4.911

8.  Reframing the dissemination challenge: a marketing and distribution perspective.

Authors:  Matthew W Kreuter; Jay M Bernhardt
Journal:  Am J Public Health       Date:  2009-10-15       Impact factor: 9.308

Review 9.  Pharmacotherapy for smoking cessation: current advances and research topics.

Authors:  Tobias Raupach; Constant P van Schayck
Journal:  CNS Drugs       Date:  2011-05       Impact factor: 5.749

10.  Quitting smoking before and after varenicline: a population study based on two representative samples of US smokers.

Authors:  Shu-Hong Zhu; Sharon E Cummins; Anthony C Gamst; Shiushing Wong; Tyson Ikeda
Journal:  Tob Control       Date:  2015-08-17       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.